Close menu




November 25th, 2021 | 13:42 CET

XPeng, Meta Materials, Aixtron - Welcome to the Metaverse

  • Technology
Photo credits: pixabay.com

Sound fundamental analysis is essential to be successful in the stock market in the long term; at least, this was the basic rule before the Reddit hype about GameStop & Co. The news that Facebook wants to reinvent itself under the name "Meta" prompted investors to buy shares in the Company of the same name. The Company is quite promising and has great potential in the long term due to the development of new materials for 5G, photovoltaics and consumer electronics. From our side, "Congratulations, dear Meta shareholders."

time to read: 3 minutes | Author: Stefan Feulner
ISIN: XPeng Inc ADR | US98422D1054 , Meta Materials Inc. | US59134N1046 , AIXTRON SE NA O.N. | DE000A0WMPJ6

Table of contents:


    Acknowledgment from the CEO

    Taking the slight mix-up in humor, Meta Materials CEO George Palikaras thanked the Company with a tweet, "On behalf of @Metamaterialtec, I'd like to welcome @Facebook to the #metaverse." The man is practiced. Already last year, the Reddit community jumped on the stock in short order. Within two days, the stock shot from USD 6 to USD 23, only to settle back in the USD 5 range. Meta Materials is not a meme stock, however, but the Company has excellent potential in terms of the technology it has developed.

    The market for metamaterials is gigantic and is growing at an annual rate of almost 24%. By 2030, the market volume is expected to reach USD 10.7 billion. Development strategies for metamaterials and functional materials focus on structures that create unusual and exotic electromagnetic properties by altering light and radio waves in ways that would be impossible naturally. Meta Materials has been successfully researching materials science for a decade.

    A bouquet of patents

    The results are impressive and demonstrate the Company's competitive advantage over its rivals. Including the patents added with the Nanotech acquisition, META now has a total of 247 patents (154 issued patents and 93 pending applications, including three design applications) in 65 patent families, of which 44 families include at least one issued patent. The total number of patents has increased 166% from 93 in 2020, and the number of patent families has more than doubled from 28 in the previous year.

    The platform company aims to continue to significantly expand the field of high-performance functional materials to protect its leadership position and capitalize on commercial opportunities with partners. The Canadians' engineered functional films can be sold in the consumer electronics, 5G communications, medical, aerospace, automotive and clean energy segments. With a stock market value of around EUR 1.20 billion, the innovation leader in metamaterials is more than promising for the long term.

    As usual for such a research company, the figures for the third quarter are marked by high losses. For the first nine months of 2021, the net loss was USD 61.5 million. In contrast, revenues rose 111% to a still-low USD 1.8 million.

    Growth continues

    One step further is the Chinese electric car Company XPeng. However, the third quarter figures also showed strong growth with an extended loss. Sales were just under USD 888.00 million, up 187.4% YOY. At 119.2%, deliveries almost cracked the 200% mark. With 25,666 vehicles, the Company was also well ahead by 47.5% compared to the previous month.

    The P7 electric sedan was the best-seller, with a total of 19,731 vehicles delivered to customers. The gross margin of XPeng was 14.4%. However, net income was again negative at USD 247.5 million. Calculated on the individual share, this means a loss of USD 0.29. Following the announcement of the figures, the Chinese investment bank CCI increased the price target from USD 60 to currently USD 69 and maintained the Outperform rating.

    Aixtron: Nosedive after buy recommendation

    Investors reacted quite harshly after a buy recommendation by analysts at Berenberg Bank. The "buy" rating was maintained, but the price target was lowered from EUR 29 to EUR 26. Analyst Charlotte Friedrichs assumes that the equipment supplier for the semiconductor industry is benefiting from high order intake but that the momentum is likely to slow for the time being. However, the analyst continues to believe in the Company's long-term potential.

    The price target reduction caused the share to fall below the critical support area at around EUR 20 and triggered a sell signal. After a sell-off below EUR 18, the stock recovered at least partially and is currently trading in the EUR 19 range again. If the daily low does not hold, the next support zone at EUR 16.80 can be identified.


    Meta Materials is the absolute innovation leader in new materials and has a competitive advantage over its competitors due to its more than 240 existing patents. XPeng continues to grow. At Aixtron, one should wait for price stabilization.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read